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ABSTRACT 
 We report a unique case of a gastric collision tumor composed of an intramural gastrin-secreting tumor and a 
papillotubular adenocarcinoma of the intestinal type discovered at autopsy in a patient with Zollinger-Ellison 
syndrome. There was extensive metastatic dissemination of the neuroendocrine component to regional lymph 
nodes and to the liver. The unusual macroscopical, histological, and immunohistochemical features of this case 
and its specific clinical setting are discussed 
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INTRODUCTION 
Admixtures of neoplastic endocrine and nonendocrine epithelial cells have been found frequently in digestive 
tumors, leading to the concept of a "carcinoma-carcinoid spectrum" [8]. This spectrum encompasses four main 
categories: (a) carcinomas with interspersed endocrine cells, (b) carcinoids with interspersed nonendocrine cells, 
(c) mixed tumors comprising both carcinoma and carcinoid areas, and (d) amphicrine tumors consisting of cells 
exhibiting both endocrine and nonendocrine differentiation. The first category is by far the most frequent one, 
comprising a large number of adenocarcinomas containing varying proportions of endocrine cells scattered 
among mucin-secreting cells and special entities such as goblet cell carcinoids of the appendix. The category of 
mixed tumors can be further subdivided into composite-type tumors, showing an admixture of the two 
histological components with frequent histological transitions, and collision-type tumors, where the two 
components, while intimately juxtaposed with a "side-by-side" or "one-upon-another" pattern, are not 
intermixed. Collision-type tumors are usually considered as double coexistent and independent tumors. Collision 
tumors of the gastrointestinal tract are much less common than the composite variety; several cases have been 
reported in the stomach [3, 10, 15], and in all of these cases the neuroendocrine component was either a 
carcinoid tumor or a malignant neuroendocrine carcinoma. To our knowledge, no such case has been associated 
with a specific clinical syndrome related to hormone hypersecretion. 
We report here what we believe is the first case of a gastric collision tumor composed of an intramural gastrin-
secreting tumor and a well-differentiated papillotubular adenocarcinoma of the intestinal type in a patient with 
Zollinger-Ellison syndrome (ZES). 
MATERIALS AND METHODS 
Clinical history 
The patient came to medical attention at the age of 87 years when he presented with massive digestive bleeding 
due to diffuse gastric, duodenal, and jejunal ulcerations, prompting a surgical antiulcer procedure (vagotomy and 
pyloroplasty). During this surgery a 1-cm intramural gastric nodule and a sessile duodenal polyp (1.5 cm) were 
incidentally found and resected. The gastric lesion proved to be a benign c-Kit positive stromal tumor, and the 
duodenal polyp was diagnosed as a villous adenoma with severe dysplasia. Following surgery and under 
antiulcer medication (20 mg/day omeprazole) digestive bleeding recurred, originating from upper jejunal 
ulcerations. ZES was then suspected. The diagnosis was confirmed definitively by marked elevation in fasting 
serum gastrin level (>3500 pg/ml), elevated basal acid output (16 mmol/h) despite the vagotomy, and 
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paradoxical increase in gastrin levels and acid output (to 36 mmol/h) after intravenous secretin infusion (3 U/kg). 
At the time of diagnosis, echoendoscopy, abdominal computed tomography with intravenous contrast, and 
selective celiac and superior mesenteric arteriography remained negative in the search of an abdominal tumor. 
Somatostatin receptor scintigraphy performed with 111In-labeled octreotide identified a single foeus of increased 
uptake in the upper right abdomen considered to be of duodenal or paraduodenal origin. The patient had no 
familial history and no associated endocrine disorders suggestive of multiple endocrine neoplasia type 1. Due to 
his general condition the patient was ineligible for surgery and was kept under high doses of antisecretory 
medications (40 mg/day omeprazole), which effectively prevented ulterior bleeding. He was readmitted to our 
hospital 4 years after the initial diagnosis, with cachexia, abdominal pain and clinical evidence of metastatic liver 
disease, confirmed by abdominal computed tomography. Surprisingly, gastros-copy revealed a large antral 
fungating mass, biopsy specimens of which showed in situ intestinal-type papillary adenocarcinoma. The patient 
died in a context of hepatorenal failure shortly after his admission. An autopsy was performed. 
Histology 
At the time of necropsy special attention was paid to the dissection of the upper abdomen in order to find the 
primary gastrinoma, to characterize the extent of the neoplastic villous gastric tumor, and to define the extent and 
origin of the metastatic dissemination. Tissue for histological examination was fixed overnight in 10% formalin, 
sectioned at 0.2-cm intervals, and embedded in paraffin. Sections 5 µm thick were stained with hematoxylin-
eosin and by immunohistochemistry. Immunoperoxidase stains were performed using a three-step indirect 
immunoperoxidase technique after antigen retrieval by microwaving the slides in citrate buffer for 20 min. 
Primary antibodies against the following antigens were used: monoclonal antibody neuron-specific enolase 
(Dako), monoclonal antibody chromogranin A (Dako), and monoclonal antibody gastrin (Immunotech). 
RESULTS 
Examination of the stomach revealed a 5.5-cm polypoid tumor on the greater curvature of the antrum. Cut 
surface showed a fungating villous pedunculated lesion and thickening of the underlying gastric wall by nodular 
and diffusely infiltrative whitish firm tumoral tissue (Fig. 1). There was no macroscopic extension through the 
serosa. The remainder of the gastric mucosa appeared smooth, and no other mucosal or intramural gastric lesion 
was identified. Three enlarged tumoral lymph nodes, measuring 1-4 cm in their greatest diameter, were found in 
the vicinity of the stomach (in retropyloric, retroduodenal, and lateroaortic locations). Most of the liver 
parenchyma was replaced by large metastatic tumor masses. Examination of the duodenum and pancreas was 
performed by serial sectioning into 3-mm slices and failed to show any tumor in these organs. Macroscopical 
appearance of the duodenal wall was unremarkable, with no evidence of residual or recurrent mucosal tumor. 
The pancreas was atrophic with ductular distension and mucoid retention. The small bowel and colon were 
unremarkable. There was no evidence of tumor outside the abdomen. 
Histopathological examination of the gastric tumor revealed two distinct microscopic appearances. The upper 
exophytic part consisted of a well-differentiated papillotubular adenocarcinoma of the intestinal type with no 
extension through the muscularis mucosae (Fig. 2a). The intramural tumor displayed microscopic features 
suggestive of a neuroendocrine proliferation (Fig. 2b). It was composed of a relatively uniform population of 
small- to medium-sized cells with an organoid, trabecular or acinar, or focally solid pattern, and frequent rosette 
formation. The nuclei had homogeneous chromatin with small or indistinct nucleoli, and showed slight variation 
in size and shape; mitoses were infrequent (< 10/10 hpf) and no necrosis was seen. The latter component 
extensively infiltrated into submucosal and subserosal lymphatic vessels and extended into the pedicle of the 
upper villous tumor. The two tumor components were abutting each other with no transition between them (Fig. 
2c). The neoplastic proliferation in all lymph nodes and in the liver exhibited an exclusively neuroendocrine 
pattern. The nontumoral gastric mucosa, macroscopically unremarkable, was found to contain exclusively 
fundic-type glands and showed nodular hyperplasia of enterochromaffin-like endocrine cells. There was no 
evidence of Helicobacter pylori gastritis or intestinal metaplasia. 
A strong immunoreactivity for neuroendocrine markers (chromogranin-A, neuron-specific enolase) and 
positivity for the Grimelius silver stain were found in the intramural gastric tumor as well in lymph nodes and 
liver metastasis, whereas the gastric epithelial tumor contained only scattered neuroendocrine cells (Fig. 2d). 
About 15% of gastric neuroendocrine neoplastic cells and 50% of lymph nodes tumor cells displayed strong 
cytoplasmic immunoreactivity to gastrin (Fig. 2e). Gastrin was not detected in liver metastasis. 
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Fig. 1 Macroscopic view of the gastric tumor 
 
 
Fig. 2 a Upper villous portion of the gastric tumor showing papillo-tubular adenocarcinoma; hematoxylin and 
eosin, original magnification ×100. b Intramural neuroendocrine portion of the gastric tumor showing rosette 
formation; hematoxylin and eosin, original magnification ×200. c Collision area between the two portions of the 
tumor; hematoxylin and eosin, original magnification ×25. d Chromogranin immunohistochemistry of the 
collision area showing strong staining of the intramural neuroendocrine tumor and isolated endocrine cells in 
the upper adenoma; immunoperoxidase, original magnification ×25. e Gastrin immunohistochemistry showing 
strong staining of some cells in the neuroendocrine component of the gastric tumor; immunoperoxidase, original 
magnification ×400 
 
 
DISCUSSION 
We report here the unique case of a gastric well-differentiated papillotubular adenocarcinoma of the intestinal 
type in collision with an intramural gastric gastrinoma. Evidence that this tumor indeed belongs to the "collision-
type" category of mixed endocrine-nonendocrine tumors is supported by the following: (a) the tumor comprised 
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two components with clearly different histological and immunohistological patterns; (b) the two components 
were macroscopically abutting each other with no histological transition between them; the upper 
adenocarcinoma was strictly intramucous in contrast to the intamural extent and the extensive lymphatic 
permeation by the underlying neuroendocrine proliferation;  and  (c)  lymph nodes and liver metastasis were 
monomorphic, displaying a neuroendocrine differentiation. To our knowledge, this case represents the first 
report of a collision tumor with a functional, secreting neuroendocrine component. 
Another peculiar feature of this case was the finding of a gastrinoma in a gastric location. Somewhat 
paradoxically, the stomach, which under physiological conditions contains most of the G cells of the organism, 
appears as a very rare site of origin for gastrinomas [7, 14, 16]. A review of the literature disclosed fewer than 20 
reported gastric gastrinomas presenting as a mucosal polyp or as unique or multiple intramural nodules [9, 12, 
13, 14]. The possibility of a primary paraduodenal nodal gastrinoma, which might have been considered from the 
scintigraphic data, was positively ruled out by the finding of a parenchymal gastrin-producing neuroendocrine 
tumor and the involvement of multiple locoregional lymph nodes. Interestingly, a study on the sensitivity and 
specificity of preoperative somatostatin receptor scintigraphy in detecting small duodenal and primary or 
metastatic nodal gastrinomas indeed found that primary duodenal tumors were missed more frequently than 
nodal metastasis at scintigraphy [2]. In the present case it is therefore much plausible that the gastric gastrinoma 
was of small size at the time of diagnosis of ZES and was not recognized at scintigraphy. 
The occurrence of a gastrinoma in our patient was associated with the development of three other primary 
digestive tumors: a benign c-kit positive gastric stromal tumor and a duodenal villous adenoma concurrent of the 
diagnosis of the ZES and a gastric adenocarcinoma several years later. It has been reported that patients 
diagnosed with carcinoid tumors are at increased risk for the development of concurrent malignancies, especially 
gastrointestinal tumors [1, 4, 5, 11]. In a series of 2837 carcinoid cases concurrent and nonconcurrent neoplasms 
were found, respectively, in 7% and 4% of the patients studied [6]. Carcinoid tumors in vitro can produce 
substances with a growth-promoting effect, and this might account for the increased incidence of tumors in 
patients with carcinoids. Gastrin has a trophic effect on the gastric mucosa, and its uncontrolled production 
might promote cell proliferation and neoplastic transformation in the adjacent mucosa by a direct paracrine 
effect. Indeed, this rare case brings additional support to this hypothesis as all associated neoplasms were found 
in the vicinity of the gastric neuroendocrine tumor. The generally low incidence of adenomas in the small 
intestine and stomach argues against unrelated events. Moreover, the absence of endoscopic evidence of gastric 
tumor at the time of diagnosis of the ZES indicates that the development of the villous tumor was subsequent to 
that of the gastrinoma. 
In conclusion, this is the first report of a gastric collision tumor functionally expressing as ZES. The additional 
finding of associated neoplasms in the immediate vicinity of the gastrinoma emphasizes the possible implication 
of gastrin in tumor growth. 
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